Advanced company searchLink opens in new window

NXERA PHARMA UK LIMITED

Company number 06267989

Filter by category

Filter by category


Confirmation statement filters, selecting an input will reload the page.
Confirmation statement filters, selecting an input will reload the page.

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
03 Jun 2026 PSC02 Notification of Nxera Pharma Co., Ltd. as a person with significant control on 6 April 2016
03 Jun 2026 PSC09 Withdrawal of a person with significant control statement on 3 June 2026
02 Jun 2026 CS01 Confirmation statement made on 30 May 2026 with no updates
29 Oct 2025 MA Memorandum and Articles of Association
23 Oct 2025 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
21 Oct 2025 AP01 Appointment of Dr Patrik Foerch as a director on 21 October 2025
21 Oct 2025 TM01 Termination of appointment of Matthew Joseph Barnes as a director on 30 September 2025
17 Oct 2025 CH01 Director's details changed for Candelle Wai Yee Chong on 30 March 2023
16 Oct 2025 CH01 Director's details changed for Candelle Wai Yee Chong on 2 November 2023
01 Aug 2025 AA Full accounts made up to 31 December 2024
09 Jun 2025 CS01 Confirmation statement made on 30 May 2025 with no updates
25 Apr 2025 AP01 Appointment of Miss Mariko Nakafuji as a director on 1 April 2025
29 Aug 2024 AA Full accounts made up to 31 December 2023
17 Jun 2024 CS01 Confirmation statement made on 30 May 2024 with updates
02 Apr 2024 CERTNM Company name changed heptares therapeutics LIMITED\certificate issued on 02/04/24
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2024-04-01
03 Aug 2023 AA Full accounts made up to 31 December 2022
30 May 2023 CS01 Confirmation statement made on 30 May 2023 with no updates
18 Apr 2023 AP01 Appointment of Candelle Wai Yee Chong as a director on 30 March 2023
06 Jan 2023 SH19 Statement of capital on 6 January 2023
  • GBP 416,406
06 Jan 2023 SH20 Statement by Directors
06 Jan 2023 CAP-SS Solvency Statement dated 22/12/22
06 Jan 2023 RESOLUTIONS Resolutions
  • RES13 ‐ Reducing share premium account 23/12/2022
22 Sep 2022 AA Full accounts made up to 31 December 2021
09 Jun 2022 CS01 Confirmation statement made on 4 June 2022 with no updates
13 May 2022 AP01 Appointment of Mr Matthew Joseph Barnes as a director on 24 March 2022